Advances in autoimmune myasthenia gravis management.

Advances in autoimmune myasthenia gravis management.
复制标题

DOI:
10.1080/14737175.2018.1491310
复制
发表时间:
2018-07
影响因子:
4.3
通讯作者:
Kaminski HJ
Kaminski HJ
中科院分区:
医学3区
文献类型:
--
作者:
Wang S;Breskovska I;Gandhy S;Punga AR;Guptill JT;Kaminski HJ

文献摘要

参考文献

被引文献

相似文献

Myasthenia gravis (MG) is an autoimmune neuromuscular disorder with no cure and conventional treatments limited by significant adverse effects and variable benefit. In the last decade, therapeutic development has expanded based on improved understanding of autoimmunity and financial incentives for drug development in rare disease. Clinical subtypes exist based on age, gender, thymic pathology, autoantibody profile, and other poorly defined factors, such as genetics, complicate development of specific therapies. Clinical presentation and pathology vary considerably among patients with some having weakness limited to the ocular muscles and others having profound generalized weakness leading to respiratory insufficiency. MG is an antibody-mediated disorder dependent on autoreactive B cells which require T cell support. Treatments focus on elimination of circulating autoantibodies or inhibition of effector mechanisms by a broad spectrum of approaches from plasmapheresis to B cell elimination to complement inhibition. Standard therapies and those under development are disease modifying and not curative. As a rare disease, clinical trials are challenged in patient recruitment. The great interest in development of treatments specific for MG is welcome, but decisions will need to be made to focus on those that offer significant benefits to patients.
DOI: 10.1016/j.cyto.2017.05.008
发表时间: 2017-08-01
期刊: CYTOKINE
影响因子: 3.8
作者:
Aguilo-Seara, Gabriela;Xie, Yanchen;Kaminski, Henry J.
通讯作者: Kaminski, Henry J.
DOI: 10.1126/science.1075958
发表时间: 2002-11-15
期刊: SCIENCE
影响因子: 56.9
作者:
Anderson, MS;Venanzi, ES;Mathis, D
通讯作者: Mathis, D
DOI: 10.1006/immu.1994.1047
发表时间: 1994-10-01
期刊: ImmunoMethods
影响因子: --
作者:
Araga, S;Blalock, J E
通讯作者: Blalock, J E
DOI: 10.1073/pnas.90.18.8747
发表时间: 1993-09-15
影响因子: 11.1
作者:
ARAGA, S;LEBOEUF, RD;BLALOCK, JE
通讯作者: BLALOCK, JE
DOI: 10.1002/mus.1221
发表时间: 2002-01-01
期刊: MUSCLE & NERVE
影响因子: 3.4
作者:
Bedlack, RS;Sanders, DB
通讯作者: Sanders, DB